Tirzepatide Helps Patients With OSA and Obesity Achieve OSA Remission Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and…
THE 2XS WAVE CLASSIC 2025: ONE TO REMEMBER! The 2XS Wave Classic at West Wittering was more than just another contest, it was a reunion, a…
SC gives Vodafone Idea a breather Vodafone Idea welcomed the decision, looking forward to working with the DoT to resolve the matter for i…
Rethinking the Flat Datum: Designing Space with Incline and Intent Explore innovative architecture that challenges flat surfaces, creating…
GLP-1 RAs Improve Glycemic, Weight Outcomes in Pediatric Obesity, Diabetes GLP-1 RA use was associated with improved cardiometabolic outco…
Lenskart Founders and Investors to Gain Massive Returns Lenskart Solutions, an eyewear manufacturer and retailer, is approaching its publi…
Delirium Risk Increased for Seniors Prescribed First-Generation Antihistamines Older adults admitted to hospitals with higher prescribing …
Early TNF Inhibitor Use Improves Outcomes in Nonsystemic JIA Early initiation of TNF inhibitors among children with non-sJIA led to signif…
Oldest Comet Ever Seen Heading for Sun The interstellar object 3I/ATLAS has gained attention from the scientific community and the general…
Tapering Methotrexate Is Feasible in Stable RA With Careful Monitoring Long-term flare risk and remission rates did not differ between pat…
Comet 3I/ATLAS Approaching the Sun The interstellar object 3I/ATLAS is expected to approach the Sun on October 29 and 30. It will p…